Stocks股票 / Health Care / TNDM
TNDM US listed · USD美股 · 美元
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software.Tandem Diabetes Care, Inc.是一家美国医疗设备公司,开发和销售胰岛素泵、自动胰岛素输送系统以及糖尿病管理软件。
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总,保留各来源报道。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-10-26Earnings财务业绩
next report下次财报 2026-11-05Estimates being cut预期下调
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
Post-earnings drift: -8.7% (20d)财报后漂移:-8.7%(20日)
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 30.9%
Valuation估值
Roughly fair vs sector相对行业估值合理| Multiple指标 | TNDM | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 7.67x | 3.57 | |
| P/S市销率 | 1.17x | 3.19 | |
| Earnings yield盈利收益率 | -17.20% | 2.37 | |
| FCF yield自由现金流收益率 | -2.49% | 3.88 | |
| Shareholder yield股东收益率 | 0.00% | 1.83 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2017 10-KThe 12-month bucket following fiscal period end 2017-12-31 is not reported. The years below are what the filing did report.文件未披露财年期末 2017-12-31 之后12个月区间的到期金额;下方为其确实披露的年度。
All maturity buckets are measured from fiscal period end 2017-12-31, not from today.所有到期区间均从财年期末 2017-12-31 起算,而非从今天起算。
Cash reported at 2025-12-31: $90634000.截至 2025-12-31 披露的现金:$90634000。 At the cash-burn pace reported over 2025-01-01 to 2025-12-31, that cash represented about 36.7 months. This scenario excludes debt payments and future financing.按 2025-01-01 至 2025-12-31 期间披露的现金消耗速度,该现金约对应 36.7 个月。此情景不包括债务偿还与未来融资。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整;不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考;缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0001564590-18-004141, period ending报告期截至 2017-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-10-04T09:25:23.217971+00:00.
1/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths— absentLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo— absentLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— period_mismatch
Annual period年度区间 2025-01-01 — 2025-12-31 · USD · 10-K · 0001438133-26-000010 · Filed提交日期 2026-02-19.
Cache acquired缓存获取时间: 2026-10-04T09:25:23.217971+00:00 · Evaluated as of评估截至 2026-10-26.
- Reported operating cash flow已披露经营活动现金流: $-9721000
- Reported equipment spending (capex outflow)已披露设备支出(资本开支流出): $19948000
- Derived free cash flow (operating cash flow minus capex)计算所得自由现金流(经营现金流减资本开支): $-29669000
Cash is the reported balance at period end. The runway scenario holds this annual cash-flow pace constant and excludes debt payments, restricted-cash adjustments and future financing.现金为期末已披露余额。现金跑道情景假设本年度现金流速度保持不变,不包括债务偿还、受限现金调整与未来融资。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Signal history信号历史
engine events引擎事件Company profile公司档案
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software.Tandem Diabetes Care, Inc.是一家美国医疗设备公司,开发和销售胰岛素泵、自动胰岛素输送系统以及糖尿病管理软件。
- Receivables stretch
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 7.7× | 3.6× | 19% |
| Price / Sales市销率 | 1.2× | 3.2× | 78% |
| Earnings yield盈利收益率 | -17.2% | 2.4% | 7% |
| Free-cash-flow yield自由现金流收益率 | -0.8% | 5.2% | 7% |
| Shareholder yield股东综合回报率 | 0.0% | 1.8% | 6% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +7.3% | -0.4% |
| 1 Month近1月 | +6.4% | -1.0% |
| 3 Months近3月 | +1.8% | +3.1% |
| 6 Months近6月 | -14.4% | +7.0% |
| Year to date年初至今 | -19.1% | +12.1% |
| 1 Year近1年 | +18.9% | +14.4% |
| 3 Years近3年 | -8.6% | +86.0% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $499M | $703M | $801M | $748M | $940M | $1.0B |
| EPS每股收益 | $-0.56 | $0.24 | $-1.47 | $-3.43 | $-1.47 | $-3.04 |
| Free cash flow自由现金流 | $-3M | $97M | $16M | $-59M | $5M | $-30M |
| Gross margin毛利率 | 52.2% | 53.5% | 51.5% | 49.2% | 52.1% | 53.8% |
| Net margin净利率 | -6.9% | 2.2% | -11.8% | -29.8% | -10.2% | -20.2% |
| FCF margin自由现金流利润率 | -0.5% | 13.8% | 2.0% | -7.8% | 0.5% | -2.9% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: strong gross profitability vs peers定价能力:毛利能力强于同业
- Capital discipline: share count +9.6% over 6 years (dilution)资本纪律:股本 6 年增加 9.6%(稀释)
- Balance sheet: Altman Z -0.04 — distress zone资产负债表:Altman Z -0.04——困境区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-0.31 | $-0.34 | +8.8% |
| Mar 2026 | $-0.30 | $-0.46 | +34.8% |
| Dec 2025 | $-0.01 | $-0.05 | +80.0% |
| Sep 2025 | $-0.31 | $-0.31 | 0.0% |
Estimate revisions预期修正
Insiders & shorts内部人与空头
Recent fund flows近期基金流向
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -9.1% | 3 |
| Feb2月 | 67% | +18.0% | 3 |
| Mar3月 | 33% | -13.4% | 3 |
| Apr4月 | 67% | +3.4% | 3 |
| May5月 | 67% | +19.1% | 3 |
| Jun6月 | 0% | -10.5% | 3 |
| Jul7月 | 33% | -7.5% | 3 |
| Aug8月 | 67% | +14.4% | 3 |
| Sep9月 | 0% | -2.0% | 4 |
| Oct10月 | 50% | +7.0% | 4 |
| Nov11月 | 67% | +19.5% | 3 |
| Dec12月 | 100% | +17.7% | 3 |